All Stories

  1. OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model

    Article • Antimicrobial Agents and Chemotherapy, February 2016, ASM Journals

    Dr Wang Hengzhuang

  2. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients

    Article • Advanced Drug Delivery Reviews, May 2015, Elsevier

    Dr Wang Hengzhuang

  3. 62 A rapid biofilm antimicrobial susceptibility assay under 24 hours for cystic fibrosis patients with Pseudomonas aeruginosa lung infection

    Article • Journal of Cystic Fibrosis, June 2014, Elsevier

    Dr Wang Hengzhuang

  4. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms

    Article • Pathogens and Disease, February 2014, Oxford University Press (OUP)

    Dr Wang Hengzhuang

  5. Pharmacokinetics and Pharmacodynamics of Antibiotics in Biofilm Infections of Pseudomonas aeruginosa In Vitro and In Vivo

    Article • January 2014, Springer Science + Business Media

    Dr Wang Hengzhuang

  6. Regulation of pqs quorum sensing via catabolite repression control in Pseudomonas aeruginosa

    Article • Microbiology, July 2013, Society for General Microbiology

    Dr Wang Hengzhuang

  7. WS17.1 Biofilm disruption and potentiating antimicrobial effects of a novel alginate oligomer on Pseudomonas aeruginosa in a murine lung infection model

    Article • Journal of Cystic Fibrosis, June 2013, Elsevier

    Dr Wang Hengzhuang

  8. High β-Lactamase Levels Change the Pharmacodynamics of β-Lactam Antibiotics in Pseudomonas aeruginosa Biofilms

    Article • Antimicrobial Agents and Chemotherapy, October 2012, ASM Journals

    Dr Wang Hengzhuang

  9. Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections

    Article • FEMS Immunology & Medical Microbiology, August 2012, Oxford University Press (OUP)

    Dr Wang Hengzhuang

  10. Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections

    Article • FEMS Immunology & Medical Microbiology, June 2012, Oxford University Press (OUP)

    Dr Wang Hengzhuang

  11. Polysaccharides serve as scaffold of biofilms formed by mucoid Pseudomonas aeruginosa

    Article • FEMS Immunology & Medical Microbiology, February 2012, Oxford University Press (OUP)

    Dr Wang Hengzhuang

  12. In VivoPharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection

    Article • Antimicrobial Agents and Chemotherapy, February 2012, ASM Journals

    Dr Wang Hengzhuang

  13. Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem on Mucoid and Nonmucoid Pseudomonas aeruginosa Biofilms

    Article • Antimicrobial Agents and Chemotherapy, June 2011, ASM Journals

    Dr Wang Hengzhuang

  14. Colistin‐Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of Biofilm Pseudomonas aeruginosa

    Article • The Journal of Infectious Diseases, November 2010, Oxford University Press (OUP)

    Dr Wang Hengzhuang